Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The patient must be between 6 and 17 years old
- The patient must have moderate to severe atopic dermatitis (a skin condition causing redness and itching) and must be currently receiving or about to start receiving dupilumab injections given under the skin
- A parent or guardian who can understand, read, and write French or English must be present and agree to participate
Who may not be able to join:
- Patients who have a diagnosed cognitive (thinking or learning) impairment that would prevent them from playing a virtual reality game
- Patients who have epilepsy, due to the nature of the virtual reality technology used in the trial
- Patients who are unable to sit upright or be positioned at an angle of at least 30 degrees during the procedure, as this is required for the virtual reality headset to work properly
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sylvie Le May, PhD, St. Justine's Hospital
Phone: 5143454931
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
mean difference in pain intensity score between sequences; mean difference in anxiety between sequences
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.